204 related articles for article (PubMed ID: 29343943)
21. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
22. Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.
Li J; Liu Y; Zhang J; Yu X; Wang X; Zhao L
Drug Des Devel Ther; 2016; 10():3699-3706. PubMed ID: 27895462
[TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacokinetics of active alkaloids after oral administration of Rhizoma Coptidis extract and Wuji Wan formulas in rat using a UPLC-MS/MS method.
Chen Y; Li Y; Wang Y; Yang Q; Dong Y; Weng X; Zhu X; Wang Y; Gong Z; Zhang R
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):67-74. PubMed ID: 24577954
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves.
Ye LH; He XX; Kong LT; Liao YH; Pan RL; Xiao BX; Liu XM; Chang Q
J Ethnopharmacol; 2014 Apr; 153(1):190-6. PubMed ID: 24561383
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs.
Zhou CJ; Qiao LM; Zhao LH; Li ZY
Fitoterapia; 2015 Dec; 107():49-53. PubMed ID: 26498206
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Cytochrome P450s by Strobilanthes crispus Sub-Fraction (F3): Implication for Herb-Drug Interaction.
Yong YF; Liew MWO; Yaacob NS
Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):431-440. PubMed ID: 35146636
[TBL] [Abstract][Full Text] [Related]
27. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats.
Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X
J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
[TBL] [Abstract][Full Text] [Related]
30. Isolation of gentiopicroside from Gentianae Radix and its pharmacokinetics on liver ischemia/reperfusion rats.
Chang-Liao WL; Chien CF; Lin LC; Tsai TH
J Ethnopharmacol; 2012 Jun; 141(2):668-73. PubMed ID: 21855624
[TBL] [Abstract][Full Text] [Related]
31. Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen).
Tian DD; Jia WW; Liu XW; Wang DD; Liu JH; Dong JJ; Li L; Du FF; Xu F; Wang FQ; Sun Y; Huang YX; Li MJ; Hu LH; Zhu Y; Gao XM; Li C; Yang JL
Acta Pharmacol Sin; 2015 May; 36(5):627-43. PubMed ID: 25891082
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
33. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of calf thymus DNA on metabolism activity of CYP450 enzyme in human liver microsomes.
Yang S; Qiu Z; Zhang Q; Chen J; Chen X
Drug Metab Pharmacokinet; 2014; 29(6):475-81. PubMed ID: 25030415
[TBL] [Abstract][Full Text] [Related]
35. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
Buchanan B; Meng Q; Poulin MM; Zuccolo J; Azike CG; Gabriele J; Baranowski DC
PLoS One; 2018; 13(3):e0194979. PubMed ID: 29579096
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.
Lee JH; Noh CK; Yim CS; Jeong YS; Ahn SH; Lee W; Kim DD; Chung SJ
J Pharm Sci; 2015 Sep; 104(9):3049-59. PubMed ID: 25648999
[TBL] [Abstract][Full Text] [Related]
38. Osthole inhibited the activity of CYP2C9 in human liver microsomes and influenced indomethacin pharmacokinetics in rats.
He H; Zhang Y; Zhao D; Jiang J; Xie B; Ma L; Liu X; Yu C
Xenobiotica; 2020 Aug; 50(8):939-946. PubMed ID: 32238050
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate.
Shi R; Zhou H; Ma B; Ma Y; Wu D; Wang X; Luo H; Cheng N
Biopharm Drug Dispos; 2012 Apr; 33(3):135-45. PubMed ID: 22344858
[TBL] [Abstract][Full Text] [Related]
40. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
